Columbus
|
The Ohio State University |
Funded |
Generated |
|
|---|---|---|---|
| ANNE M STROHECKER, PHD
Regulation of Autophagy by the Small GTPase Rab20 |
[Lung Cancer]
2015 |
$60,000 |
|
| JENNIFER L LEIGHT, PHD
Impact of the tumor microenvironment on matrix metalloproteinase activity |
[Cancer Therapy]
2015 |
$60,000 |
|
| VICTOR JIN, PHD
Microenvironmental Influences on AKT1-regulated Transcriptome in Tumorigenesis |
[Breast Cancer]
2011 |
$60,000 |
|
| KEIKO AKAGI, PHD
Bioinformatics Analysis of Genomic Mutations in Chronic Lymphocytic Leukemia |
[Leukemia]
2011 |
$30,000 |
|
| NINA MAYR, MD
Towards Optimal Radiation Therapy:Radiobiological Modeling of Prostate Cancer |
[Prostate Cancer]
2010 |
$60,000 |
|
| JIAN-QUI WU, PHD
Phosphorylation of the Anillin Md 1 p bt Polo Kinase During Cytokinesis |
[Molecular Genetics]
2008 |
$25,000 |
$1,657,958 |
| ROBERT A BAIOCCHI, MD, PHD
Role of the Arginine Methyltansferase PRMT5 in B cell Transformation |
[Lymphoma]
2007 |
$50,000 |
$908,523 |
| RAMI AQEILAN, PHD
Role of the WW Domain-Containing Oxidoreductase (WWOX) Gene in Skeletal Development and Bone Neoplasia |
[Tumor Cells Research]
2007 |
$50,000 |
$1,506,126 |
| SAMIR ACHARYA, PHD
Role of Mismatch Repair in Cell Survival |
[Colon Cancer]
2007 |
$24,726 |
$100,000 |
| HAROLD A FISK, PHD
Regulation of the Centrosomal Degradation of the Mps1 Protein Kinase Melanoma-specific CTL Peptide |
[Molecular Genetics]
2007 |
$50,000 |
$2,046,717 |
| XUE-FENG BAI, MD, PHD
Novel Strategies to Overcome Antigenic Drift |
[Gene Mutation]
2005 |
$50,000 |
$981,060 |
| DUXIN SUN, PHD
Targeted Prodrug Delivery for Cancer Therapy |
[Chemotherapy]
2005 |
$50,000 |
$1,758,726 |
| SUSAN E COLE, PHD
Modulation of Lunatic fringe gene activity and Notch signaling in the segmentation |
[Molecular Genetics]
2005 |
$50,000 |
$832,277 |
| LAURA ANN KRESTY, PHD
Reversing Epigenetic Changes Through HDAC Inhibition A Tool for Cancer |
[Esophageal Cancer]
2005 |
$49,919 |
$330,000 |
| STEFAN NIEWIESK, DVM, PHD
Induction of oncolysis in Adut T Cell Leukemia Through Heat Shock Protein Induction and Measles Virus Co-Infection |
[Leukemia]
2005 |
$50,000 |
$3,203,590 |
| WERNER TJARKS, PHD
Synthesis of Boron and Gadolinium Containing Texaphyrins For NCT of Head and Neck Cancer |
[Head and Neck Cancer]
2003 |
$50,000 |
$1,305,039 |
| KARL ANDREW WERBOVETZ, PHD
Characterization of the Tubulin Peptide Binding Site |
[Chemotherapy]
2002 |
$50,000 |
|
| DENIS C GUTTRIDGE, PHD
NF-kappa B Regulation of Cell Growth Control in G1/S |
[Molecular Studies]
2002 |
$50,000 |
$1,853,191 |
| MICHAEL E WEINSTEIN, PHD
Functions of Smad2 in Mesodermal Differentiation and Tumor Progression |
[Molecular Genetics]
2001 |
$50,000 |
$20,000 |
| PAN ZHENG, MD
Antigen Presentation Defects in Prostate Cancer |
[Prostate Cancer]
1999 |
$50,000 |
$778,500 |
| SUNG YOON, PHD
Determination of upstream regulators of p75-mediated JNK activation |
[Molecular Genetics]
1999 |
$46,000 |
$3,524,081 |
| PAIVI PELTOMAKI, MD, PHD
Genetic basis of tumor spectrum in hereditary nonpolyposis colon cancer |
[Colon Cancer]
1999 |
$45,000 |
$496,575 |
| GREGORY OTTERSON, MD
Molecular Changes in Nonsmall Cell Lung Cancer |
[Lung Cancer]
1999 |
$46,000 |
$2,214,946 |
| LOUIS MANSKY, PHD
Human T-Cell Leukemia Virus Type 1 RNA Encapsidation |
[Leukemia]
1999 |
$46,000 |
$512,568 |
| TSONWIN HAI, PHD
Caspases in ATF3-Induced Apoptosis |
[Molecular Genetics]
1999 |
$48,000 |
$1,209,505 |
| JAMES WILLIAM DEWILLE, MPH MS PHD
Mammary tumors express a C/EBP-b transcritpion inhibitor |
[Breast Cancer]
1997 |
$39,600 |
$2,929,435 |
| PAUL KENNETH HERMAN, PHD
GO and the control of eukaryotic cell proliferation |
[Molecular Genetics]
1997 |
$40,000 |
$3,575,863 |
| SISSY M JHIANG, PHD
Gene Transfer of Na/I Symporter Tumors for Radioiodine Treatment |
[Brain Cancer]
1997 |
$40,000 |
$2,690,831 |
| AMANDA SIMCOX, PHD
Identification of Novel Componets in the Drosophila EGF-Receptor Signaling |
[Molecular Genetics]
1997 |
$40,000 |
$306,600 |
| HARALD VAESSIN, PHD
Regulation of Cdk inhibitor expression |
[Molecular Genetics]
1997 |
$38,389 |
$325,085 |
| MARSHALL VANCE WILLIAMS, PHD
Fluorodeoxyuridine, dUTPASE and Colorectal Cancer |
[Colon Cancer]
1995 |
$38,318 |
|
| DARRELL R GALLOWAY, PHD
Development and Analysis of a Recombinant Protein for the Melanoma-specific CTL Peptide |
[Skin Cancer]
1995 |
$20,000 |
|
| MICHAEL D LAIRMORE, DVM, PHD
Mechanisms of Regulation of Human T-Lymphotropic Virus |
[Lymphoma]
1991 |
$39,993 |
$18,027,125 |
| ROBERT W CURLEY, JR PHD
NMR Studies of Drug-Recepto Ineractions Chemopreventive Retinoids |
[Chemoprevention]
1991 |
$20,000 |
$129,000 |
| ING-MING CHIU, PHD
Molecular Lesion of 5q- Chromosome in Acute Non-Lymphocytic Leukemia (ANLL) Patients |
[Leukemia]
1988 |
$39,000 |
$6,988,789 |
| ARTHUR L SAGONE, JR MD
Importance of the HMPS Pathway in the Matabolism of Tumor Tissue |
[Hematology]
1988 |
$35,100 |
|
| BRENT C BEHRENS, MD
Evaluation of Proton NMR Spectroscopy as an Indicator of Tumor Burden |
[Molecular Genetics]
1988 |
$15,762 |
|
| BRUCE S ZWILLING, PHD
Cyclic AMP Dependent Protein Kinase, Regulation of Macrophage Antiturmor |
[Gene Mutation]
1986 |
$35,557 |
|
| DAVID H IVES, PHD
Development of Solid-Phase Immunoassays for Human Deoxynucleoside Kinase Isoenzymes |
[Molecular Genetics]
1986 |
$34,348 |
$614,514 |
| ROBERT W BRUEGGEMEIER, PHD
Examination of Steroid-Protein Ineractions 12 Using 19f-NMR Spectroscopy |
[Breast Cancer]
1983 |
$18,850 |
$4,491,883 |
| LEE F JOHNSON, PHD
Determination of the Primary Structure of Mammalian Thymidlylate Synthetase |
[Thyroid Cancer]
1983 |
$48,140 |
$2,776,436 |
| LOUIS MALSPEIS, PHD
Pharmocologic and Pharmakinetic Studies of Cancer Drugs-Equipment |
[Chemotherapy Delivery]
1983 |
$40,644 |
|
| JOHN RINEHART, PHD
Evalution of Biologic Modifiers and Chemotherapeutics |
[Chemotherapy]
1983 |
$59,376 |
|
| JAMES SHAW, PHD
Production of Monoclonal Antibody To EBV-Induced DNA Polymerase |
[Gene Mutation]
1983 |
$18,850 |
|
| DEBORAH S PARRIS, PHD
Function of Herpes Simplex Virus Deoxribonuclease |
[Molecular Genetics]
1983 |
$43,587 |
$4,006,291 |
| MARY MACVICAR, RN, PHD
Effects of Bicycle Ergometer Program in Functional Status of Women with Breast Cancer |
[Breast Cancer]
1982 |
$17,357 |
$497,307 |
| GEORGE E MILO, PHD
Evaluation of Human Tumors by Clonogenic Array |
[Gene Mutation]
1982 |
$14,796 |
|
|
TOTAL: |
$1,938,312 |
$72,598,541 |
|
Nationwide Children’s Hospital |
Funded |
Generated |
|
|---|---|---|---|
| RISA KITAGAWA, PHD
Securin function in cancer and development |
[Tumor Studies] 2011 |
$30,000 |
|
| JOAN DURBIN, MD, PHD
The Role of the PAX3FKHR Fusion Gene in the Development of Rhabdomyosarcoma |
[Rhabdomyosarcoma] 1999 |
$45,000 |
$1,431,149 |
| NATARAJAN MUTHUSAMY, DVM, PHD
Defining thr role of Ets-1 transcription factor in B lymphocyte growth and didderentiation |
[Lymphoma] 1999 |
$45,000 |
$919,800 |
| SUE O’DORISIO, MD, PHD
Vasoactive Intestinal Peptides: Neuromodulator of the Immune Response |
[Gastrointestinal] 1986 |
$39,986 |
$910,452 |
|
TOTAL: |
$159,986 |
$3,261,401 |